The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, OptumRx and Express Scripts.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

So now I don't have my prescription, and the actual physical CVS won't fill my prescription because it's too soon to fill it. I feel like someone has tampered with my medication. And I don't want ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' narrative. UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ten or more,

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension drug.

The "RIG" portfolio aims for 50% income from defensive sectors and includes 83 stocks across 11+ sectors, focusing on investment-grade stocks. Explore more details here.

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from price gouging.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty generic drugs,